000			02197nam a2200457 i 4500
999			_c268305 _d268305
001			on1015373781
003			BD
005			20180410220350.0
006			m o d f
007			cr bn||||a||||
008			171215s2017 dcu ol f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dGPO _dMvI
042			_apcc
043			_an-us---
049			_aOnline
074			_a0575-A-02 (online)
086	0		_aAE 2.110:115-52
088			_aPublic Law 115-52
099			_aAE 2.110:115-52
110	1		_aUnited States, _eenacting jurisdiction.
240	1	0	_aFDA Reauthorization Act of 2017
245	1	3	_aAn Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes.
264		1	_a[Washington, D.C.] : _b[U.S. Government Publishing Office], _c2017.
300			_a1 online resource ([86] pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
500			_a"Aug. 18, 2017 (H.R. 2430)."
500			_a"131 Stat. 1005."
500			_a"Public Law 115-52."
500			_aCRDP Program record.
588			_aDescription based on online resource; title from PDF title screen (FDsys, viewed on Dec. 15, 2017).
650		0	_aDrugs _xPrices _xLaw and legislation _zUnited States.
650		0	_aPrescription pricing _xLaw and legislation _zUnited States.
650		0	_aMedical instruments and apparatus industry _xLaw and legislation _zUnited States.
650		0	_aGeneric drugs _xPrices _zUnited States.
650		0	_aBiologicals _xLaw and legislation _zUnited States.
650		0	_aUser charges _xLaw and legislation _zUnited States.
655		7	_aStatutes and codes. _2lcgft
776	0	8	_iPrint version: _aUnited States. _sFDA Reauthorization Act of 2017. _tAct to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes _w(OCoLC)1015373866
856	4	0	_3PDF version _uhttp://purl.fdlp.gov/GPO/gpo87296
856	4	0	_3Text version _uhttp://purl.fdlp.gov/GPO/gpo87297
942			_2sudocs _c8